Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Peritoneal Cancer market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Peritoneal Cancermarket, defines the market attractiveness level of Peritoneal Cancer market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Peritoneal Cancer industry, describes the types of Peritoneal Cancer market, the applications of major players and the market size, and deeply analyzes the current situation of the global Peritoneal Cancer market and the development prospects and opportunities of Peritoneal Cancer industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Peritoneal Cancer market in Chapter 13.
By Player:
Millennium Pharmaceuticals
GlaxoSmithKline
Oasmia Pharmaceutical
Oncolytics Biotech
Synta Pharmaceuticals
Bayer
Oxford BioMedica
Incyte
Novartis
EntreMed
AstraZeneca
By Type:
Surgery
Chemotherapy (Anticancer Drugs)
Radiotherapy (High-Energy Rays)
By End-User:
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Peritoneal Cancer Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Peritoneal Cancer Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Peritoneal Cancer Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Peritoneal Cancer Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Peritoneal Cancer Market Analysis and Outlook to 2022
-
7.1 Global Peritoneal Cancer Consumption (2017-2022)
-
7.2 United States Peritoneal Cancer Consumption (2017-2022)
-
7.3 Europe Peritoneal Cancer Consumption (2017-2022)
-
7.4 China Peritoneal Cancer Consumption (2017-2022)
-
7.5 Japan Peritoneal Cancer Consumption (2017-2022)
-
7.6 India Peritoneal Cancer Consumption (2017-2022)
-
7.7 South Korea Peritoneal Cancer Consumption (2017-2022)
8 Region and Country-wise Peritoneal Cancer Market Analysis and Outlook to 2028
-
8.1 Global Peritoneal Cancer Consumption Forecast (2022-2028)
-
8.2 United States Peritoneal Cancer Consumption Forecast (2022-2028)
-
8.3 Europe Peritoneal Cancer Consumption Forecast (2022-2028)
-
8.4 China Peritoneal Cancer Consumption Forecast (2022-2028)
-
8.5 Japan Peritoneal Cancer Consumption Forecast (2022-2028)
-
8.6 India Peritoneal Cancer Consumption Forecast (2022-2028)
-
8.7 South Korea Peritoneal Cancer Consumption Forecast (2022-2028)
9 Global Peritoneal Cancer Market Outlook by Types and Applications to 2022
-
9.1 Global Peritoneal Cancer Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Surgery Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Chemotherapy (Anticancer Drugs) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Radiotherapy (High-Energy Rays) Consumption and Growth Rate (2017-2022)
-
9.2 Global Peritoneal Cancer Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Research Centers Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Surgical Centers Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Clinics Consumption and Growth Rate (2017-2022)
10 Global Peritoneal Cancer Market Outlook by Types and Applications to 2028
-
10.1 Global Peritoneal Cancer Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Chemotherapy (Anticancer Drugs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Radiotherapy (High-Energy Rays) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Peritoneal Cancer Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global Peritoneal Cancer Import and Export Analysis (Top 5 Countries)
-
11.1 Global Peritoneal Cancer Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Peritoneal Cancer Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Peritoneal Cancer Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Peritoneal Cancer Market Competitive Analysis
-
14.1 Millennium Pharmaceuticals
-
14.1.1 Millennium Pharmaceuticals Company Details
-
14.1.2 Millennium Pharmaceuticals Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Millennium Pharmaceuticals Peritoneal Cancer Product and Service
-
14.2 GlaxoSmithKline
-
14.2.1 GlaxoSmithKline Company Details
-
14.2.2 GlaxoSmithKline Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GlaxoSmithKline Peritoneal Cancer Product and Service
-
14.3 Oasmia Pharmaceutical
-
14.3.1 Oasmia Pharmaceutical Company Details
-
14.3.2 Oasmia Pharmaceutical Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Oasmia Pharmaceutical Peritoneal Cancer Product and Service
-
14.4 Oncolytics Biotech
-
14.4.1 Oncolytics Biotech Company Details
-
14.4.2 Oncolytics Biotech Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Oncolytics Biotech Peritoneal Cancer Product and Service
-
14.5 Synta Pharmaceuticals
-
14.5.1 Synta Pharmaceuticals Company Details
-
14.5.2 Synta Pharmaceuticals Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Synta Pharmaceuticals Peritoneal Cancer Product and Service
-
14.6 Bayer
-
14.6.1 Bayer Company Details
-
14.6.2 Bayer Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bayer Peritoneal Cancer Product and Service
-
14.7 Oxford BioMedica
-
14.7.1 Oxford BioMedica Company Details
-
14.7.2 Oxford BioMedica Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Oxford BioMedica Peritoneal Cancer Product and Service
-
14.8 Incyte
-
14.8.1 Incyte Company Details
-
14.8.2 Incyte Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Incyte Peritoneal Cancer Product and Service
-
14.9 Novartis
-
14.9.1 Novartis Company Details
-
14.9.2 Novartis Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis Peritoneal Cancer Product and Service
-
14.10 EntreMed
-
14.10.1 EntreMed Company Details
-
14.10.2 EntreMed Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 EntreMed Peritoneal Cancer Product and Service
-
14.11 AstraZeneca
-
14.11.1 AstraZeneca Company Details
-
14.11.2 AstraZeneca Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 AstraZeneca Peritoneal Cancer Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Peritoneal Cancer
-
Figure Peritoneal Cancer Picture
-
Table Global Peritoneal Cancer Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peritoneal Cancer Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Peritoneal Cancer Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Peritoneal Cancer Consumption by Country (2017-2022)
-
Figure United States Peritoneal Cancer Consumption and Growth Rate (2017-2022)
-
Table Europe Peritoneal Cancer Consumption and Growth Rate (2017-2022)
-
Figure China Peritoneal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Japan Peritoneal Cancer Consumption and Growth Rate (2017-2022)
-
Figure India Peritoneal Cancer Consumption and Growth Rate (2017-2022)
-
Figure South Korea Peritoneal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Peritoneal Cancer Consumption Forecast by Country (2022-2028)
-
Figure United States Peritoneal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Peritoneal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Peritoneal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Peritoneal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Peritoneal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Peritoneal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgery Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy (Anticancer Drugs) Consumption and Growth Rate (2017-2022)
-
Figure Global Radiotherapy (High-Energy Rays) Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Research Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Surgical Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy (Anticancer Drugs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiotherapy (High-Energy Rays) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Research Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Peritoneal Cancer Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Peritoneal Cancer Export by Region (Top 5 Countries) (2017-2028)
-
Table Millennium Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Millennium Pharmaceuticals Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Millennium Pharmaceuticals Peritoneal Cancer Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Peritoneal Cancer Product and Service
-
Table Oasmia Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Oasmia Pharmaceutical Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oasmia Pharmaceutical Peritoneal Cancer Product and Service
-
Table Oncolytics Biotech (Foundation Year, Company Profile and etc.)
-
Table Oncolytics Biotech Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oncolytics Biotech Peritoneal Cancer Product and Service
-
Table Synta Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Synta Pharmaceuticals Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Synta Pharmaceuticals Peritoneal Cancer Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Peritoneal Cancer Product and Service
-
Table Oxford BioMedica (Foundation Year, Company Profile and etc.)
-
Table Oxford BioMedica Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oxford BioMedica Peritoneal Cancer Product and Service
-
Table Incyte (Foundation Year, Company Profile and etc.)
-
Table Incyte Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Incyte Peritoneal Cancer Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Peritoneal Cancer Product and Service
-
Table EntreMed (Foundation Year, Company Profile and etc.)
-
Table EntreMed Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table EntreMed Peritoneal Cancer Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Peritoneal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Peritoneal Cancer Product and Service
-
